Synteract talks rescue studies at DIA 2011
Synteract says the use of non-validated data systems in clinical trials is a key driver for the ‘rescue study’ segment of the contract research sector.
Synteract says the use of non-validated data systems in clinical trials is a key driver for the ‘rescue study’ segment of the contract research sector.
US Government Officials have implored ten major pharmaceutical companies to give up information in the race to solve the 2007-2008 contaminated Chinese herparin incident.
Gerresheimer is interested in a US acquisition as part of a bid to build in the North American plastic drug packaging sector.
Scientists at the University of British Columbia have pioneered a magnetic retinal implant that can supply a regulated and on-demand release of drugs to treat blindness from diabetic retinopathy.
A WTO panel has ruled China’s export limits on raw materials, including some with pharma uses, are unfair after claims they drive up prices.
Contract research organisation (CRO) Chiltern International has upped its investment in IVR/IWR tech firm endpoint.
Sponsors can cut onsite visits and increase trial efficiency by using data management systems more effectively, according to an industry survey.